Research output per year
Research output per year
Research output
- 13 Journal article
Search results
-
2015
Predictive role of HER2/neu, topoisomerase-II-alpha, and tissue inhibitor of metalloproteinases (TIMP-1) for response to adjuvant taxane-based chemotherapy in patients with intermediate-risk breast cancer: results from the WSG-AGO EC-Doc trial
Erber, R., Gluz, O., Brünner, N., Kreipe, H. H., Pelz, E., Kates, R., Bartels, A., Huober, J., Mohrmann, S., Moustafa, Z., Liedtke, C., Möbus, V., Augustin, D., Thomssen, C., Jänicke, F., Kiechle, M., Kuhn, W., Nitz, U., Harbeck, N. & Hartmann, A., Apr 2015, In: Breast Cancer Research and Treatment. 150, 2, p. 279-288 10 p.Research output: Contribution to journal › Journal article › Research › peer-review
-
2014
TIMP-1 and responsiveness to gemcitabine in advanced breast cancer: results from a randomized phase III trial from the Danish breast cancer cooperative group
Jørgensen, C. L. T., Bjerre, C. A., Ejlertsen, B. L., Bjerre, K. D., Balslev, E., Bartels, A., Brünner, N. & Nielsen, D. L., 22 May 2014, In: B M C Cancer. 14, 14 p., 360.Research output: Contribution to journal › Journal article › Research › peer-review
-
2013
Is TIMP-1 immunoreactivity alone or in combination with other markers a predictor of benefit from anthracyclines in the BR9601 adjuvant breast cancer chemotherapy trial?
Munro, A. F., Bartels, A., Balslev, E., Twelves, C. J., Cameron, D. A., Brünner, N. & Bartlett, J. M., 9 Apr 2013, In: Breast Cancer Research (Online Edition). 15, 2, 8 p., R31.Research output: Contribution to journal › Journal article › Research › peer-review
-
2012
TIMP-1 in combination with HER2 and TOP2A for prediction of benefit from adjuvant anthracyclines in high-risk breast cancer patients
Hertel, P. B., Tu, D., Ejlertsen, B. L., Jensen, M-B. R., Balslev, E., Jiang, S., O'Malley, F. P., Pritchard, K. I., Shepherd, L. E., Bartels, A., Brunner, N. & Nielsen, T. O., Feb 2012, In: Breast Cancer Research and Treatment. 132, 1, p. 225-234 10 p.Research output: Contribution to journal › Journal article › Research › peer-review
-
2011
Evaluating TIMP-1, Ki67, and HER2 as markers for non-sentinel node metastases in breast cancer patients with micrometastases to the sentinel node
Tvedskov, T. F., Bartels, A., Jensen, M-B., Paaschburg, B., Kroman, N., Balslev, E. & Brünner, N., Dec 2011, In: APMIS Supplementum. 119, 12, p. 844-852 9 p.Research output: Contribution to journal › Journal article › Research › peer-review
-
2010
Expression of matrix metalloproteinase 9 (MMP-9) and tissue inhibitor of metalloproteinases 1 (TIMP-1) by colorectal cancer cells and adjacent stroma cells - associations with histopathology and patients outcome
Jensen, S. A., Vainer, B., Bartels, A., Brunner, N. & Sørensen, J. B., Dec 2010, In: European Journal of Cancer. 46, 18, p. 3233-3242 10 p.Research output: Contribution to journal › Journal article › Research › peer-review
-
Expression of matrix metalloproteinase 9 (MMP-9) and tissue inhibitor of metalloproteinases 1 (TIMP-1) by colorectal cancer cells and adjacent stroma cells--associations with histopathology and patients outcome
Jensen, S. A., Vainer, B., Bartels, A., Brünner, N. & Sørensen, J. B., Dec 2010, In: European journal of cancer (Oxford, England : 1990). 46, 18, p. 3233-42 10 p.Research output: Contribution to journal › Journal article › Research › peer-review
-
Lack of relationship between TIMP-1 tumour cell immunoreactivity, treatment efficacy and prognosis in patients with advanced epithelial ovarian cancer
Steffensen, K. D., Waldstrøm, M., Christensen, R. K., Bartels, A., Brunner, N. & Jakobsen, A., 7 May 2010, In: BMC Cancer. 10, 185, 10 p.Research output: Contribution to journal › Journal article › Research › peer-review
-
2009
High frequency of tumor cells with nuclear Egr-1 protein expression in human bladder cancer is associated with disease progression
Egerod, F. N. S. L., Bartels, A., Fristrup, N., Borre, M., Ørntoft, T. F., Oleksiewicz, M. B., Brunner, N. & Dyrskjøt, L., 2009, In: BMC Cancer. 9, 385, 8 p.Research output: Contribution to journal › Journal article › Research › peer-review
-
Lack of TIMP-1 tumour cell immunoreactivity predicts effect of adjuvant anthracycline-based chemotherapy in patients (n=647) with primary breast cancer: A Danish Breast Cancer Cooperative Group Study
Willemoe, G. L., Hertel, P. B., Bartels, A., Jensen, M-B., Balslev, E., Rasmussen, B. B., Mouridsen, H. T., Ejlertsen, B. L. & Brunner, N., 2009, In: European Journal of Cancer. 45, 14, p. 2528-2536 9 p.Research output: Contribution to journal › Journal article › Research › peer-review
-
Low expression of tissue inhibitor of metalloproteinases-1 (TIMP-1) in glioblastoma predicts longer patient survival
Aaberg-Jessen, C., Christensen, K., Offenberg, H. K., Bartels, A., Dreehsen, T., Hansen, S., Schrøder, H. D., Brunner, N. & Kristensen, B. W., 2009, In: Journal of Neuro-Oncology. 95, 1, p. 117-128 12 p.Research output: Contribution to journal › Journal article › Research › peer-review
-
PPARa and PPAR¿ coactivation rapidly induces Egr-1 in the nuclei of the dorsal and ventral urinary bladder and kidney pelvis urothelium of rats
Egerod, F. L., Svendsen, J. E., Hinley, J., Southgate, J., Bartels, A., Brünner, N. & Oleksiewicz, M. B., 2009, In: Toxicologic Pathology. 37, 7, p. 947-958 12 p.Research output: Contribution to journal › Journal article › Research › peer-review
-
2007
Identification of alternatively spliced TIMP-1 mRNA in cancer cell lines and colon cancer tissue
Usher, P. A., Sieuwerts, A. M., Bartels, A., Lademann, U., Nielsen, H. J., Holten-Andersen, L., Foekens, J. A., Brünner, N. & Offenberg, H. K., 2007, In: Molecular Oncology. 1, 2, p. 205-215 11 p.Research output: Contribution to journal › Journal article › Research › peer-review